Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.
Lundin A, Dietrichs E, Haghighi S, Göller ML, Heiberg A, Loutfi G, Widner H, Wiktorin K, Wiklund L, Svenningsson A, Sonesson C, Waters N, Waters S, Tedroff J. Lundin A, et al. Among authors: svenningsson a. Clin Neuropharmacol. 2010 Sep-Oct;33(5):260-4. doi: 10.1097/WNF.0b013e3181ebb285. Clin Neuropharmacol. 2010. PMID: 20616707 Clinical Trial.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Salzer J, Svenningsson R, Alping P, Novakova L, Björck A, Fink K, Islam-Jakobsson P, Malmeström C, Axelsson M, Vågberg M, Sundström P, Lycke J, Piehl F, Svenningsson A. Salzer J, et al. Among authors: svenningsson a, svenningsson r. Neurology. 2016 Nov 15;87(20):2074-2081. doi: 10.1212/WNL.0000000000003331. Epub 2016 Oct 19. Neurology. 2016. PMID: 27760868 Free PMC article.
Season of birth and multiple sclerosis in Sweden.
Salzer J, Svenningsson A, Sundström P. Salzer J, et al. Among authors: svenningsson a. Acta Neurol Scand. 2010 Jan;121(1):20-3. doi: 10.1111/j.1600-0404.2009.01181.x. Epub 2009 Nov 23. Acta Neurol Scand. 2010. PMID: 19930210 Corrected and republished.
Season of birth and multiple sclerosis in Sweden.
Salzer J, Svenningsson A, Sundström P. Salzer J, et al. Among authors: svenningsson a. Acta Neurol Scand. 2010 Jul;122(1):70-3. doi: 10.1111/j.1600-0404.2010.01396.x. Acta Neurol Scand. 2010. PMID: 20597868
Automated determination of brain parenchymal fraction in multiple sclerosis.
Vågberg M, Lindqvist T, Ambarki K, Warntjes JB, Sundström P, Birgander R, Svenningsson A. Vågberg M, et al. Among authors: svenningsson a. AJNR Am J Neuroradiol. 2013 Mar;34(3):498-504. doi: 10.3174/ajnr.A3262. Epub 2012 Sep 13. AJNR Am J Neuroradiol. 2013. PMID: 22976234 Free PMC article.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R, Askmark H, Svenningsson A, Andersen O, Axelson HW, Strömberg U, Wahlin A, Isaksson C, Johansson JE, Hägglund H. Press R, et al. Among authors: svenningsson a. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):618-24. doi: 10.1136/jnnp-2013-306014. Epub 2013 Nov 21. J Neurol Neurosurg Psychiatry. 2014. PMID: 24262917
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J. Burman J, et al. Among authors: svenningsson a. J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19. J Neurol Neurosurg Psychiatry. 2014. PMID: 24554104
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC. Warnke C, et al. Among authors: svenningsson a. Mult Scler. 2015 Jul;21(8):1036-44. doi: 10.1177/1352458514556296. Epub 2014 Nov 12. Mult Scler. 2015. PMID: 25392339
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Svenningsson A, Bergman J, Dring A, Vågberg M, Birgander R, Lindqvist T, Gilthorpe J, Bergenheim T. Svenningsson A, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Feb 26;2(2):e79. doi: 10.1212/NXI.0000000000000079. eCollection 2015 Apr. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25745637 Free PMC article.
Vitamin D and axonal injury in multiple sclerosis.
Sandberg L, Biström M, Salzer J, Vågberg M, Svenningsson A, Sundström P. Sandberg L, et al. Among authors: svenningsson a. Mult Scler. 2016 Jul;22(8):1027-31. doi: 10.1177/1352458515606986. Epub 2015 Oct 13. Mult Scler. 2016. PMID: 26462862
Rituximab in paediatric onset multiple sclerosis: a case series.
Salzer J, Lycke J, Wickström R, Naver H, Piehl F, Svenningsson A. Salzer J, et al. Among authors: svenningsson a. J Neurol. 2016 Feb;263(2):322-326. doi: 10.1007/s00415-015-7979-x. Epub 2015 Nov 24. J Neurol. 2016. PMID: 26603152
Reply.
Alping P, Frisell T, Svenningsson A, Piehl F. Alping P, et al. Among authors: svenningsson a. Ann Neurol. 2016 Nov;80(5):791-792. doi: 10.1002/ana.24767. Epub 2016 Sep 27. Ann Neurol. 2016. PMID: 27553863 No abstract available.
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.
Vågberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y, Granberg T, Gunnarsson M, von Heijne A, Jönsson L, Karrenbauer VD, Larsson EM, Lindqvist T, Lycke J, Lönn L, Mentesidou E, Müller S, Nilsson P, Piehl F, Svenningsson A, Vrethem M, Wikström J. Vågberg M, et al. Among authors: svenningsson a. Acta Neurol Scand. 2017 Jan;135(1):17-24. doi: 10.1111/ane.12667. Epub 2016 Aug 24. Acta Neurol Scand. 2017. PMID: 27558404 Free PMC article. Review.
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Novakova L, Zetterberg H, Sundström P, Axelsson M, Khademi M, Gunnarsson M, Malmeström C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J. Novakova L, et al. Among authors: svenningsson a. Neurology. 2017 Nov 28;89(22):2230-2237. doi: 10.1212/WNL.0000000000004683. Epub 2017 Oct 27. Neurology. 2017. PMID: 29079686 Free PMC article.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ. Bridel C, et al. Among authors: svenningsson a. JAMA Neurol. 2019 Sep 1;76(9):1035-1048. doi: 10.1001/jamaneurol.2019.1534. JAMA Neurol. 2019. PMID: 31206160 Free PMC article.
Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis.
Muhallab S, Lundberg C, Gielen AW, Lidman O, Svenningsson A, Piehl F, Olsson T. Muhallab S, et al. Among authors: svenningsson a. Scand J Immunol. 2002 Mar;55(3):264-73. doi: 10.1046/j.0300-9475.2002.01038.x. Scand J Immunol. 2002. PMID: 11940233 Free article.
[Treatment of status epilepticus].
Salzer J, Svenningsson A. Salzer J, et al. Among authors: svenningsson a. Lakartidningen. 2012 Jun 5-19;109(23-24):1170-1. Lakartidningen. 2012. PMID: 22834211 Swedish. No abstract available.
Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.
Wickström A, Sundström P, Wickström L, Dahle C, Vrethem M, Svenningsson A. Wickström A, et al. Among authors: svenningsson a. Mult Scler J Exp Transl Clin. 2015 Sep 22;1:2055217315608203. doi: 10.1177/2055217315608203. eCollection 2015 Jan-Dec. Mult Scler J Exp Transl Clin. 2015. PMID: 28607705 Free PMC article.
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.
Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Lindå H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Hammarberg H, et al. Among authors: svenningsson a. J Neurosci. 2000 Jul 15;20(14):5283-91. doi: 10.1523/JNEUROSCI.20-14-05283.2000. J Neurosci. 2000. PMID: 10884312 Free PMC article.
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
Sorensen PS, Mellgren SI, Svenningsson A, Elovaara I, Frederiksen JL, Beiske AG, Myhr KM, Søgaard LV, Olsen IC, Sandberg-Wollheim M. Sorensen PS, et al. Among authors: svenningsson a. Lancet Neurol. 2009 Jun;8(6):519-29. doi: 10.1016/S1474-4422(09)70085-7. Epub 2009 May 4. Lancet Neurol. 2009. PMID: 19409854 Free article. Clinical Trial.
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J. Gunnarsson M, et al. Among authors: svenningsson a. Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8. Ann Neurol. 2011. PMID: 21280078
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Al Nimer F, Elliott C, Bergman J, Khademi M, Dring AM, Aeinehband S, Bergenheim T, Romme Christensen J, Sellebjerg F, Svenningsson A, Linington C, Olsson T, Piehl F. Al Nimer F, et al. Among authors: svenningsson a. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e191. doi: 10.1212/NXI.0000000000000191. eCollection 2016 Feb. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 26770997 Free PMC article.
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Alping P, Frisell T, Novakova L, Islam-Jakobsson P, Salzer J, Björck A, Axelsson M, Malmeström C, Fink K, Lycke J, Svenningsson A, Piehl F. Alping P, et al. Among authors: svenningsson a. Ann Neurol. 2016 Jun;79(6):950-8. doi: 10.1002/ana.24651. Epub 2016 Apr 20. Ann Neurol. 2016. PMID: 27038238 Clinical Trial.
Lumbar puncture preferences among Swedish neurologists.
Salzer J, Sundström P, Vågberg M, Svenningsson A. Salzer J, et al. Among authors: svenningsson a. Neurol Res. 2015 Jan;37(1):92-4. doi: 10.1179/1743132814Y.0000000442. Epub 2014 Sep 12. Neurol Res. 2015. PMID: 25213597
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies.
Spelman T, Magyari M, Piehl F, Svenningsson A, Rasmussen PV, Kant M, Sellebjerg F, Joensen H, Hillert J, Lycke J. Spelman T, et al. Among authors: svenningsson a. JAMA Neurol. 2021 Oct 1;78(10):1197-1204. doi: 10.1001/jamaneurol.2021.2738. JAMA Neurol. 2021. PMID: 34398221 Free PMC article.
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Longinetti E, Bower H, McKay KA, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Piehl F, Frisell T. Longinetti E, et al. Among authors: svenningsson a. Ann Clin Transl Neurol. 2022 Sep;9(9):1449-1458. doi: 10.1002/acn3.51646. Epub 2022 Aug 22. Ann Clin Transl Neurol. 2022. PMID: 35993445 Free PMC article.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
Svenningsson A, Frisell T, Burman J, Salzer J, Fink K, Hallberg S, Hambraeus J, Axelsson M, Nimer FA, Sundström P, Gunnarsson M, Johansson R, Mellergård J, Rosenstein I, Ayad A, Sjöblom I, Risedal A, de Flon P, Gilland E, Lindeberg J, Shawket F, Piehl F, Lycke J. Svenningsson A, et al. Lancet Neurol. 2022 Aug;21(8):693-703. doi: 10.1016/S1474-4422(22)00209-5. Lancet Neurol. 2022. PMID: 35841908 Clinical Trial.
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline.
Johansson M, Stomrud E, Johansson PM, Svenningsson A, Palmqvist S, Janelidze S, van Westen D, Mattsson-Carlgren N, Hansson O. Johansson M, et al. Among authors: svenningsson a. Biol Psychiatry. 2022 Jul 1;92(1):34-43. doi: 10.1016/j.biopsych.2022.01.012. Epub 2022 Jan 31. Biol Psychiatry. 2022. PMID: 35346458 Free article.
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
He A, Merkel B, Brown JWL, Zhovits Ryerson L, Kister I, Malpas CB, Sharmin S, Horakova D, Kubala Havrdova E, Spelman T, Izquierdo G, Eichau S, Trojano M, Lugaresi A, Hupperts R, Sola P, Ferraro D, Lycke J, Grand'Maison F, Prat A, Girard M, Duquette P, Larochelle C, Svenningsson A, Petersen T, Grammond P, Granella F, Van Pesch V, Bergamaschi R, McGuigan C, Coles A, Hillert J, Piehl F, Butzkueven H, Kalincik T; MSBase study group. He A, et al. Among authors: svenningsson a. Lancet Neurol. 2020 Apr;19(4):307-316. doi: 10.1016/S1474-4422(20)30067-3. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199096
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.
Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T. Alping P, et al. Among authors: svenningsson a. Ann Neurol. 2020 May;87(5):688-699. doi: 10.1002/ana.25701. Epub 2020 Mar 9. Ann Neurol. 2020. PMID: 32056253 Free article.
Serum sickness following rituximab therapy in multiple sclerosis.
Holmøy T, Fogdell-Hahn A, Svenningsson A. Holmøy T, et al. Among authors: svenningsson a. Neurol Clin Pract. 2019 Dec;9(6):519-521. doi: 10.1212/CPJ.0000000000000685. Neurol Clin Pract. 2019. PMID: 32042497 Free PMC article. No abstract available.
140 results